Skip to main content

Michael J. Fox Foundation: Development and Validation of Improved Outcome Measures in Parkinson's

Michael J. Fox Foundation: Development and Validation of Improved Outcome Measures in Parkinson's

Award Amount: Up to $750,000 for up to two years
Application Due Date: 
October 22, 2020

Additional Information -
The Michael J. Fox Foundation (MJFF) seeks applications to develop objective biomarkers that can support therapeutic development in Parkinson’s.

These may include biomarkers that improve definitive diagnosis, objectively track disease progression, enrich for subject populations, or more precisely detect a treatment response or target engagement. The availability of these types of biomarkers would transform clinical trial design and assist in the interpretation of trial results.

Applications should focus on studies that achieve one or more of the following for Parkinson’s:
- Develop or validate promising biomarkers of disease
- Develop or validate prodromal biomarkers
- Develop or validate biomarkers of phenoconversion
- Develop or validate specific molecular biomarker assays
- Analyze and derive candidate biomarkers from existing biological datasets
- Develop and support remote assessment strategies that could complement in-clinic assessments

This program is not appropriate for:
- Therapeutic development
- Interventional studies
- Literature/landscape review or assessment

Link to Complete RFP

If you are interested in applying, please reach out to Lynn Wong or Gwen Allouch with the Office of Advancement.